Mi Haonan, Oh Christopher, Towheed Tanveer
Department of Medicine, Queen's University, Kingston, Canada.
Eur J Rheumatol. 2023 Feb 6;11(Suppl 1):S53-67. doi: 10.5152/eurjrheum.2023.21197.
Hand osteoarthritis is a common disease with significant morbidity. This review aimed to update our earlier systematic reviews which included all published randomized controlled trials evaluating pharmacological and non-pharmacological therapies in patients with hand osteoarthritis. A total of 133 randomized controlled trials evaluating pharmacological and nonpharmacological therapies in hand osteoarthritis were reviewed. Overall, the methodological quality of randomized controlled trials has improved since the last update. Almost all new studies described their methods for randomization, blinding, and allocation concealment. However, studies continued to underreport features specific to hand osteoarthritis, such as pattern of joint involvement and number of affected joints. Standardized outcome assessments for pain and function were commonly presented, but measures of other hand osteoarthritis specific outcomes, such as health-related quality of life and patient global assessments, continued to be underreported. Future trials should consistently report on hand osteo arthritis specific features and outcome assessments in order to make clinically relevant conclusions about the efficacy of the diverse treatment options available.
手部骨关节炎是一种常见且发病率颇高的疾病。本综述旨在更新我们早期的系统评价,其中纳入了所有已发表的评估手部骨关节炎患者药物治疗和非药物治疗的随机对照试验。总共对133项评估手部骨关节炎药物治疗和非药物治疗的随机对照试验进行了综述。总体而言,自上次更新以来,随机对照试验的方法学质量有所提高。几乎所有新研究都描述了其随机化、盲法和分配隐藏的方法。然而,研究对于手部骨关节炎的特定特征,如关节受累模式和受累关节数量,仍报道不足。疼痛和功能的标准化结局评估较为常见,但其他手部骨关节炎特定结局的测量,如健康相关生活质量和患者整体评估,仍报道不足。未来的试验应始终如一地报告手部骨关节炎的特定特征和结局评估,以便就现有多种治疗方案的疗效得出具有临床相关性的结论。